92 related articles for article (PubMed ID: 25274249)
1. Thrombin generation in the presence of platelets is sensitive to the activation status of von Willebrand factor.
Pelkmans L; Miszta A; Al Dieri R; de Laat B; Kelchtermans H
Thromb Haemost; 2015 Jan; 113(1):209-11. PubMed ID: 25274249
[No Abstract] [Full Text] [Related]
2. Genotyping might help therapeutic decision-making in patients with von Willebrand disease type 2 B.
Rugeri L; Fretigny M; Dargaud Y; Nougier C; Vinciguerra C
Haemophilia; 2016 Sep; 22(5):e439-43. PubMed ID: 27353798
[No Abstract] [Full Text] [Related]
3. Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality.
Castaman G; Federici AB
Semin Thromb Hemost; 2016 Jul; 42(5):478-82. PubMed ID: 27148840
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective α-granule secretion.
Langer F; Obser T; Oyen F; Spath B; Holstein K; Greinacher A; White JG; Budde U; Bokemeyer C; Schneppenheim R
Thromb Haemost; 2014 Apr; 111(4):777-9. PubMed ID: 24337418
[No Abstract] [Full Text] [Related]
5. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
6. An update on type 2B von Willebrand disease.
Mikhail S; Aldin ES; Streiff M; Zeidan A
Expert Rev Hematol; 2014 Apr; 7(2):217-31. PubMed ID: 24521271
[TBL] [Abstract][Full Text] [Related]
7. Biomedicine. Contact--how platelets touch von Willebrand factor.
Sadler JE
Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
[No Abstract] [Full Text] [Related]
8. A role for von Willebrand factor in Streptococcus sanguis-induced platelet activation.
McNicol A; Eyer E; Jackson EC; Israels SJ
Thromb Haemost; 2007 Dec; 98(6):1382-4. PubMed ID: 18064343
[No Abstract] [Full Text] [Related]
9. von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism.
Ulrichts H; Vanhoorelbeke K; Cauwenberghs S; Vauterin S; Kroll H; Santoso S; Deckmyn H
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1302-7. PubMed ID: 12775575
[TBL] [Abstract][Full Text] [Related]
10. The cleaved peptide of PAR1 results in a redistribution of the platelet surface GPIb-IX-V complex to the surface-connected canalicular system.
Furman MI; Nurden P; Berndt MC; Nurden AT; Benoit SE; Barnard MR; Ofosu FA; Michelson AD
Thromb Haemost; 2000 Nov; 84(5):897-903. PubMed ID: 11127874
[TBL] [Abstract][Full Text] [Related]
11. Structure and function of platelet membrane glycoproteins Ib and V. Effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin.
Wicki AN; Clemetson KJ
Eur J Biochem; 1985 Nov; 153(1):1-11. PubMed ID: 2933256
[TBL] [Abstract][Full Text] [Related]
12. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
13. Targeting platelet GPIbβ reduces platelet adhesion, GPIb signaling and thrombin generation and prevents arterial thrombosis.
Maurer E; Tang C; Schaff M; Bourdon C; Receveur N; Ravanat C; Eckly A; Hechler B; Gachet C; Lanza F; Mangin PH
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1221-9. PubMed ID: 23559635
[TBL] [Abstract][Full Text] [Related]
14. The glycoprotein Ib-IX-V complex in platelet adhesion and signaling.
Andrews RK; Shen Y; Gardiner EE; Dong JF; López JA; Berndt MC
Thromb Haemost; 1999 Aug; 82(2):357-64. PubMed ID: 10605725
[No Abstract] [Full Text] [Related]
15. False normal von Willebrand factor activity by monoclonal antibody-based ELISA in a patient with type 2A(IID) von Willebrand disease.
Ahmad S; Ptashkin B; DiGiovanni C; Cines DB; Konkle BA; Cuker A
Thromb Haemost; 2011 Dec; 106(6):1224-5. PubMed ID: 21979291
[No Abstract] [Full Text] [Related]
16. Functional analysis of three recombinant A1-VWF domain mutants in comparison to wild type and plasma-derived VWF facilitates subtyping in type 2 von Willebrand disease.
Chegeni R; Vickars L; Favaloro EJ; Lillicrap D; Othman M
Thromb Res; 2011 Feb; 127(2):161-6. PubMed ID: 21094983
[TBL] [Abstract][Full Text] [Related]
17. Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist.
Berny MA; White TC; Tucker EI; Bush-Pelc LA; Di Cera E; Gruber A; McCarty OJ
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):329-34. PubMed ID: 17962622
[TBL] [Abstract][Full Text] [Related]
18. [Determination of the detachment force of platelet membrane protein GPIb/IX and von Willebrand factor].
Wang Y; Gao Z; Hu Y; Hu Q; Yang C; Zhuang F
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Jun; 26(3):590-4, 605. PubMed ID: 19634679
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
de Romeuf C; Hilbert L; Mazurier C
Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
[TBL] [Abstract][Full Text] [Related]
20. RETRACTED: Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin.
Baglia FA; Badellino KO; Li CQ; Lopez JA; Walsh PN
J Biol Chem; 2002 Jan; 277(3):1662-8. PubMed ID: 11696542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
